Fig. 3From: The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatmentsRisk allocation: comparison of relative prevalence reduction after 15Â years using a proportional versus a most efficient injecting risk targeted treatment and vaccination strategy. PWID people who inject drugsBack to article page